Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The Portrait Toxigenic Clostridium difficile assay is a rapid, qualitative assay for the detection of the tcdB gene of C. difficile in stool specimens from patients suspected of C. difficile infections, and received 510(k) clearance by the US FDA in March 2012. The Portrait Toxigenic C. difficile assay combines novel blocked-primer-mediated helicase-dependent multiplex amplification (bpHDA) technology and chip-based detection in an automated sample-to-result format. The assay requires minimal sample preparation and results are available within 90 min. In a multicenter evaluation, the Portrait Toxigenic C. difficile assay had a sensitivity of 98.2% and specificity of 92.8% compared with toxigenic culture. A comparative study between the Portrait Toxigenic C. difficile assay and three FDA-cleared molecular assays for the detection of toxigenic C. difficile exhibited a high degree of agreement (93.8-97.5%). The Portrait Toxigenic C. difficile assay provides a simple, cost-effective method with broad applicability to panel-based approaches, potentially simplifying workflow.

Original languageEnglish (US)
Pages (from-to)17-26
Number of pages10
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Clostridium difficile
Clostridium Infections
Workflow
Technology
Costs and Cost Analysis
Sensitivity and Specificity

Keywords

  • C. difficile infections
  • Clostridium difficile
  • Diagnostic test
  • Helicase-dependent amplification
  • Isothermal tcdB amplification
  • Nucleic acid amplification tests
  • Portrait Toxigenic C. difficile assay
  • Sensitivity, specificity
  • Toxigenic culture

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

@article{946e6c436a04481896abed21f63289f4,
title = "Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens",
abstract = "The Portrait Toxigenic Clostridium difficile assay is a rapid, qualitative assay for the detection of the tcdB gene of C. difficile in stool specimens from patients suspected of C. difficile infections, and received 510(k) clearance by the US FDA in March 2012. The Portrait Toxigenic C. difficile assay combines novel blocked-primer-mediated helicase-dependent multiplex amplification (bpHDA) technology and chip-based detection in an automated sample-to-result format. The assay requires minimal sample preparation and results are available within 90 min. In a multicenter evaluation, the Portrait Toxigenic C. difficile assay had a sensitivity of 98.2{\%} and specificity of 92.8{\%} compared with toxigenic culture. A comparative study between the Portrait Toxigenic C. difficile assay and three FDA-cleared molecular assays for the detection of toxigenic C. difficile exhibited a high degree of agreement (93.8-97.5{\%}). The Portrait Toxigenic C. difficile assay provides a simple, cost-effective method with broad applicability to panel-based approaches, potentially simplifying workflow.",
keywords = "C. difficile infections, Clostridium difficile, Diagnostic test, Helicase-dependent amplification, Isothermal tcdB amplification, Nucleic acid amplification tests, Portrait Toxigenic C. difficile assay, Sensitivity, specificity, Toxigenic culture",
author = "Gerald Denys",
year = "2014",
month = "1",
day = "1",
doi = "10.1586/14737159.2014.864239",
language = "English (US)",
volume = "14",
pages = "17--26",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens

AU - Denys, Gerald

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The Portrait Toxigenic Clostridium difficile assay is a rapid, qualitative assay for the detection of the tcdB gene of C. difficile in stool specimens from patients suspected of C. difficile infections, and received 510(k) clearance by the US FDA in March 2012. The Portrait Toxigenic C. difficile assay combines novel blocked-primer-mediated helicase-dependent multiplex amplification (bpHDA) technology and chip-based detection in an automated sample-to-result format. The assay requires minimal sample preparation and results are available within 90 min. In a multicenter evaluation, the Portrait Toxigenic C. difficile assay had a sensitivity of 98.2% and specificity of 92.8% compared with toxigenic culture. A comparative study between the Portrait Toxigenic C. difficile assay and three FDA-cleared molecular assays for the detection of toxigenic C. difficile exhibited a high degree of agreement (93.8-97.5%). The Portrait Toxigenic C. difficile assay provides a simple, cost-effective method with broad applicability to panel-based approaches, potentially simplifying workflow.

AB - The Portrait Toxigenic Clostridium difficile assay is a rapid, qualitative assay for the detection of the tcdB gene of C. difficile in stool specimens from patients suspected of C. difficile infections, and received 510(k) clearance by the US FDA in March 2012. The Portrait Toxigenic C. difficile assay combines novel blocked-primer-mediated helicase-dependent multiplex amplification (bpHDA) technology and chip-based detection in an automated sample-to-result format. The assay requires minimal sample preparation and results are available within 90 min. In a multicenter evaluation, the Portrait Toxigenic C. difficile assay had a sensitivity of 98.2% and specificity of 92.8% compared with toxigenic culture. A comparative study between the Portrait Toxigenic C. difficile assay and three FDA-cleared molecular assays for the detection of toxigenic C. difficile exhibited a high degree of agreement (93.8-97.5%). The Portrait Toxigenic C. difficile assay provides a simple, cost-effective method with broad applicability to panel-based approaches, potentially simplifying workflow.

KW - C. difficile infections

KW - Clostridium difficile

KW - Diagnostic test

KW - Helicase-dependent amplification

KW - Isothermal tcdB amplification

KW - Nucleic acid amplification tests

KW - Portrait Toxigenic C. difficile assay

KW - Sensitivity, specificity

KW - Toxigenic culture

UR - http://www.scopus.com/inward/record.url?scp=84893082130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893082130&partnerID=8YFLogxK

U2 - 10.1586/14737159.2014.864239

DO - 10.1586/14737159.2014.864239

M3 - Article

C2 - 24308336

AN - SCOPUS:84893082130

VL - 14

SP - 17

EP - 26

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 1

ER -